Improving the Precision of Immunotherapies Through Cell Targeting
Johnson & Johnson Innovation is seeking innovations in cell targeting technology that are highly selective towards immune cells, with a focus on macrophages and fibroblasts, capable of effectively delivering a drug payload to its target on or within the cell of interest. Technologies that enable intracellular delivery are of greatest interest.
Specific Points of Interest
- Selective targeting of immune cells focusing on macrophages, fibroblasts and also including dendritic cells, myeloid cells, monocytes, T-cells, B-cells, NK cells and neutrophils, including...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile